Fatty acid binding proteins shape the cellular response to activation of the glucocorticoid receptor

Glucocorticoids are steroid hormones that are essential for life in mammals. Therapeutically, they are some of the most cost-effective drugs for the treatment of inflammatory diseases ranging from skin rashes to COVID-19, but their use is limited by adverse effects. Glucocorticoids exert their effects via the glucocorticoid receptor, a type I nuclear hormone receptor which modulates gene expression. The transcriptional activity of some related, but nuclear restricted, type II nuclear hormone receptors can be enhanced by a family of intracellular transport proteins, the fatty acid binding proteins (FABPs). We find that the transcriptional activity of the GR can be altered by a sub-set of FABP family members dependent on the GR-ligand. The ability of some FABPs to selectively promote or limit the transcriptional activity of the GR in a ligand-dependent manner could facilitate the discovery of drugs that narrow GR activity to only the desired subset of therapeutically relevant genes. ### Competing Interest Statement The work was supported in part by funding from Les Laboratories Servier. Authors DV, FM, CB, AG, JPS, CD, PG, WG and RJW were employed by Les Laboratories Servier, a commercial company, at the time this study was conducted. There are no patents, products in development or marketed products to declare.